- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.09. | Trump calls for some childhood vaccines be split into smaller doses | ||
| 21.09. | J&J firms up Caplyta's 1st phase 3 win in bipolar-associated manic episodes | ||
| 21.09. | IntraBio's Aqneursa scores expansion, now the first treatment for rare ataxia | ||
| 21.09. | Novo struggles to appease restive investors with consumer plans, blockbuster ambitions | ||
| 21.09. | New MFN deal details reignite concerns that Trump's pricing policy favors pharma | ||
| 21.09. | Bayer offloads cancer drug Stivarga to Grünenthal for up to $431M as new competition looms | ||
| 21.09. | The Oral GLP-1 Tracker: Holiday takes toll on prescriptions | ||
| 18.09. | Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo | ||
| 18.09. | Europe's CHMP endorses slew of new medicines, including new offerings from Novo and AstraZeneca | ||
| 18.09. | Panthers and zebras and meerkats, oh my: A peek behind the curtain at Fierce Pharma Week 2026 | ||
| 18.09. | Fierce Pharma Asia-China deals safe from COINS?; Key WCLC data; Legend's new CEO | ||
| 17.09. | FDA approves Ultragenyx's gene therapy Fayuvi for rare neurodegenerative disorder | ||
| 17.09. | Eli Lilly dishes out fresh produce to cultivate Alzheimer's awareness | ||
| 17.09. | Bayer's Kerendia secures FDA nod as first drug in 30 years for Type 1 diabetes-associated kidney disease | ||
| 17.09. | Roche's Lunsumio delivers positive confirmatory trial readout in follicular lymphoma | ||
| 17.09. | Bavarian Nordic secures Sanofi, AstraZeneca vet to fill shoes of longtime CEO Paul Chaplin | ||
| 17.09. | Sun Pharma shines a light on alopecia areata in 'Regrowth Restyled' campaign | ||
| 17.09. | FDA drops warning letter on Bausch & Lomb, citing contamination concerns | ||
| 17.09. | 'People like the sincerity of it': comedian Damon Wayans on humor, relatability and DME awareness in Genentech campaign | ||
| 17.09. | Ex-PHM CEO Andrea Palmer takes top job at Assembled Intelligence | ||
| 16.09. | Vera's strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry | ||
| 16.09. | Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts | ||
| 16.09. | Trialynx Wins DPHARM Idol Disrupt 2026 | ||
| 16.09. | BMS, Ono take Amgen to task as FDA's Opdivo biosimilar decision looms | ||
| 16.09. | Reckitt allots $600 million in upgrade of its U.S. operations |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.